Neurology Devices are specialized surgical devices used for the treatment of disease or conditions of the Central Nervous System (CNS) and spine. Neurovascular Coiling Assist Devices are used during coiling interventions to help hold coils in place as they are placed inside the aneurysm. GlobalData uses proprietary data and analytics to provide a comprehensive report on the neurovascular coiling assist devices devices market, including market shares of different players within the UK. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the neurovascular coiling assist devices market in the UK was Stryker followed by MicroVention, Medtronic, Cerenovus and Balt.
Neurovascular Coiling Assist Devices can be Coil Assist Stents or Coil Assist Balloons. Coil Assist Stents are Stents that are placed in the vessel with the aneurysm. Coil Assist Balloons are deployed in the vessel with the aneurysm.
The value of the neurovascular coiling assist devices devices market within the UK was expected to be over $9m in 2023.
For the latest complete market share analysis of neurovascular coiling assist devices device market in the UK, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
